Posted on 04/18/2020 4:52:16 PM PDT by SeekAndFind
NEW YORK--(BUSINESS WIRE)--Hydroxychloroquine, a widely available and inexpensive drug initially used for malaria as well as lupus and rheumatoid arthritis, has been the subject of intense medical and political debate as researchers work quickly to determine its ability to fight coronavirus. According to this week’s Sermo COVID-19 Real Time Barometer of 5,158 physicians, one-quarter of global physicians agree that healthcare workers should take hydroxychloroquine to prevent COVID-19 infections with 50% having used or seen hydroxychloroquine used in their professional settings since March 25, 2020.
There is little data about the efficacy of hydroxychloroquine, and the Centers for Disease Control and Prevention (CDC) has cited cardiotoxicity as a leading concern with the treatment, particularly in patients with underlying health issues and immunosuppression.
Hydroxychloroquine use among patients:
In the US alone, there are more than 24 hydroxychloroquine trials underway to test the drug’s capabilities for preventing and treating coronavirus. While universities like NYU Langone Medical School are evaluating whether hydroxychloroquine can prevent people exposed to the novel coronavirus from getting sick and states like South Dakota are conducting their own clinical trials, physicians are increasingly tasked with making real-time decisions based on the limited information available.
Prophylactic use of Hydroxychloroquine for patients:
By the first week of April 2020, of the physicians who had prescribed hydroxychloroquine to their patients, 22% of them had already prescribed or had seen hydroxychloroquine prescribed prophylactically in their setting (n=1443).
While most patient types receiving hydroxychloroquine were high risk (including first responders), a significant share of physicians had even used hydroxychloroquine for low risk patients:
Hydroxychloroquine usage for suspected undiagnosed cases:
Findings from the Sermo study also reveal that physicians have prescribed hydroxychloroquine for both symptomatic patients and undiagnosed patients, and the use of hydroxychloroquine in clinical settings has been on the rise since March 25, 2020. As of April 8, 50% of global physicians have used or seen hydroxychloroquine used in their professional settings (Week 1, March 25: 33%; Week 2, April 1: 44%; Week 3, April 8th: 50%).
Additionally, physicians reported the patient types they are treating with hydroxychloroquine include:
N= physicians who have prescribed hydroxychloroquine (W1: 2573, W2: 1443)
An anonymous emergency medicine physician on Sermo commented: “Despite the superstorm of controversy surrounding hydroxychloroquine, it still remains the leading treatment option for severe patients and is even being used in milder cases and patients who are simply suspected of COVID. At this stage with so little evidence, doctors have very limited options.”
Sermo’s COVID-19 Real Time Barometer observational study polled over 20,000 expert physicians in 30 countries, including the United States, Canada, United Kingdom, France, Brazil, Russia, China, Japan and Australia. All data published to date can be found here.
About Sermo
Sermo is the largest healthcare data collection company and social platform for physicians, reaching 1,3MM HCPs across 150 countries. The platform enables doctors to anonymously talk real-world medicine, review treatment options via our proprietary Drug Ratings platform, collectively solve patient cases, and participate in medical market research. For more information, visit sermo.com.
Would be great if we can get HCQ over the counter for widespread prevention.
RE: Would be great if we can get HCQ over the counter for widespread prevention.
Before we do that, please read Post #2 above.
Not a majority, or ripping off a page of MSM playbook, “75% of doctors are opposed”
Thanks, saving it on my computer, ya never know.
“I have bad news for those who raise their hopes on Hydroxychloroquine possibly protecting against Covid-19...
More than five dozen people with chronic ailments like lupus and rheumatoid arthritis were taking medications such as hydroxychloroquine before being diagnosed with the coronavirus...”
Yeah, I call bullshiite. Out of how many? Bet they scanned over 10,000 records.
Five dozen out of how many?
RE: Yeah, I call bullshiite. Out of how many? Bet they scanned over 10,000 records.
Unfortunately, I can’t analyze the content of the report as WSJ is behind a paywall.
Maybe another article will reference this that doesn’t require payment. Let’s wait before we conclude...
HCQ must be taken w Zinc (forms of which are OTC) to improve effectiveness against covid 19. Studies of HCQ only vs covid are incomplete at best.
It may be too much to hope for that the drug will prevent infections. The important questions are does it help slow or even prevent progression, inhibit viral replication, and buy the body time to build its own immune response.
Other questions about dosage need to be answered.
It may be a small data set, but curious to know among those who were on HQC who became infected what is the rate of hospitalizations, intubations, death etc. (And the dosing of each person is likely to be a wide range.) That would be important to know... but the data set may be just too small to draw any conclusions, especially if it turns out that the prevalence of disease is 50-85 times higher than active infections suggest - it means a lot of asymptomatic and minimally symptomatic cases were out there.
Most global physicians are not much past witchdoctors.
I just got my scrip for it yesterday. Convinced my PCP. Told her I was “going to Africa, and didn’t want to get malaria.” With air quotes. And asked for it. Got a big eyeroll and smirk, and she prescribed it.
$15 Winn Dixie. They had it. 30 x 200mg.
Took two this am, will take two more in a few. Will follow the India Protocol.
Hydroxychloroquine is classified as a “immunosuppressive” which suggest HCQ is NOT a good prevention. Quercetin and HCQ both bond the your hemoglobin they’re both used as an ionophore and alkaline(neutralizes the viroprotein
Dozens of cases with probably a high number of exposures
I think this speaks to the prophylactic nature
Tests that does NOT use the drugs suggested by the source doctors should not be treated as science.
you're article intentionally misleads people to believe something that isn't true.
If i said to take X, Y and Z(zinc.) you take X and Y without Z. is that the same thing?
RE: Tests that does NOT use the drugs suggested by the source doctors should not be treated as science.
Hang on, the article says:
“Dozens of people taking hydroxychloroquine and other treatments for chronic rheumatologic diseases have become infected with Covid-19, according to an analysis of emerging data that is a sign the drugs may not protect people from the new coronavirus.”
Exactly what ELSE does the source doctor suggest? And who is this source doctor anyway?
Remember, we’re talking about PROPHYLAXIS, not treatment.
It’s in it. 1/3 of 9500, which is 3,166. 190 reported they had it. 6%. That’s higher than current % worldwide..?
We’ll see. They imply it’s a worldwide survey. Self selected respondents.
RE: If i said to take X, Y and Z(zinc.) you take X and Y without Z. is that the same thing?
The above protocol you described is for patients who ALREADY HAVE Covid-19 and need to be treated.
The Wall Street Journal article ( behind a paywall unfortunately ) on the other hand, is talking about PROTECTING People who were NOT infected from becoming infected by using HCQ alone.
So, if you are an Un-infected person, do you need to add Zinc and Azythromicyin to HCQ as well in order to be protected? Is that what the source doctor ( whoever he is ) recommends?
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.